Nuntius Therapeutics
PrivateLast Round
Seed
Mar 23, 2021
Est. Valuation
$1.79M
Total Funding Raised
$125,000
Company Overview
Nuntius Therapeutics operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Seed round in March 2021.
Nuntius Therapeutics is a biotechnology company that develops mRNA and gene-editing therapies using a proprietary, machine-learning-driven nanocarrier platform for cell-specific delivery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nuntius Therapeutics Comparables
Compare Nuntius Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Code Biotherapeutics | 80% | |
| Apertura Gene Therapy | 74% | |
| Bristol Myers Squibb | 73% |
For institutional investors. Book with your work email.
Nuntius Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Nuntius Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Backed VC | Seed |
| FoundersX Ventures | Seed |
| Uncommon Denominator | Seed |
| Asymmetry Ventures | Seed |
| Y Combinator | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2026
Monthly visitors increased 32% MoM.
- Mar 23, 2021
$125K round led by Y Combinator
For institutional investors. Book with your work email.
Nuntius Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nuntius Therapeutics's valuation, stock price, and market status.
Is Nuntius Therapeutics a public or private company?
Nuntius Therapeutics is a private company.
What is the current stock price of Nuntius Therapeutics?
Nuntius Therapeutics is a private company, so its shares have no public market price. Caplight tracks Nuntius Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nuntius Therapeutics worth (valuation)?
Nuntius Therapeutics's valuation is estimated at $1.8M based on funding round data.
Can I buy Nuntius Therapeutics stock?
Nuntius Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nuntius Therapeutics's last funding round?
Nuntius Therapeutics's most recent funding round was Seed on March 23, 2021.
Who are the main investors in Nuntius Therapeutics?
Key investors in Nuntius Therapeutics include Y Combinator.
Will Nuntius Therapeutics IPO soon?
No public IPO plans have been announced for Nuntius Therapeutics.
How can I track Nuntius Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Nuntius Therapeutics's shares on secondary markets.